1-methyl-7-(naphthalen-1-ylmethoxy)-9H-pyrido[3,4-b]indole

ID: ALA2164707

PubChem CID: 54767535

Max Phase: Preclinical

Molecular Formula: C23H18N2O

Molecular Weight: 338.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nccc2c1[nH]c1cc(OCc3cccc4ccccc34)ccc12

Standard InChI:  InChI=1S/C23H18N2O/c1-15-23-21(11-12-24-15)20-10-9-18(13-22(20)25-23)26-14-17-7-4-6-16-5-2-3-8-19(16)17/h2-13,25H,14H2,1H3

Standard InChI Key:  UDUMVLIVSFJGGL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 30  0  0  0  0  0  0  0  0999 V2000
   11.5611  -24.5293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5600  -25.3566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2747  -25.7695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2730  -24.1164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9884  -24.5256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9886  -25.3520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7747  -25.6072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.7743  -24.2700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2585  -24.9365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0758  -24.8496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4100  -24.0969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.9207  -23.4303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1051  -23.5204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8452  -25.7685    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5614  -25.5165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1310  -25.3555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1316  -24.5305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8462  -24.1188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8488  -23.2974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1365  -22.8804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4156  -24.1188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4215  -23.2924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7100  -22.8759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9920  -23.2847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9901  -24.1142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7022  -24.5269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  9  1  0
  8  5  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  2 14  1  0
 10 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 17 21  2  0
 18 19  2  0
 19 20  1  0
 20 22  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
M  END

Associated Targets(Human)

OE33 (225 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hs 683 (377 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T98G (1524 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 338.41Molecular Weight (Monoisotopic): 338.1419AlogP: 5.76#Rotatable Bonds: 3
Polar Surface Area: 37.91Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.53CX Basic pKa: 6.15CX LogP: 4.56CX LogD: 4.54
Aromatic Rings: 5Heavy Atoms: 26QED Weighted: 0.45Np Likeness Score: -0.23

References

1. Frédérick R, Bruyère C, Vancraeynest C, Reniers J, Meinguet C, Pochet L, Backlund A, Masereel B, Kiss R, Wouters J..  (2012)  Novel trisubstituted harmine derivatives with original in vitro anticancer activity.,  55  (14): [PMID:22770529] [10.1021/jm300542e]
2. Meinguet C, Bruyère C, Frédérick R, Mathieu V, Vancraeynest C, Pochet L, Laloy J, Mortier J, Wolber G, Kiss R, Masereel B, Wouters J..  (2015)  3D-QSAR, design, synthesis and characterization of trisubstituted harmine derivatives with in vitro antiproliferative properties.,  94  [PMID:25747498] [10.1016/j.ejmech.2015.02.044]

Source